Pàgina inicial > Resultats de la cerca: Inhaled corticosteroids
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.03 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
23 p, 3.1 MB Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations : SABINA Findings From Europe and North America / Quint, Jennifer K. (Imperial College London) ; Arnetorp, Sofie (Payer Analytics. AstraZeneca) ; Kocks, Janwillem W.H. (University Medical Center Groningen) ; Kupczyk, Maciej (Karolinska Institutet (Estocolm, Suècia)) ; Nuevo, Javier (Evidence Generation. AstraZeneca) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Cabrera, Claudia (BioPharmaceuticals Medical (Evidence). AstraZeneca) ; Raherison-Semjen, Chantal (Bordeaux University) ; Walker, Brandie (University of Calgary) ; Penz, Erika (University of Saskatchewan) ; Gilbert, Ileen (Medical Affairs. AstraZeneca) ; Lugogo, Njira Lucia (University of Michigan) ; van der Valk, Ralf J.P. (Medical Affairs. AstraZeneca) ; Fong, Andrew ; Qian, Christina ; Fabry-Vendrand, Caroline ; Touboul, Chantal ; Brzostek, Dorota ; Maslova, Ekaterina ; Surmont, Filip ; Goike, Helena ; Gandhi, Hitesh ; Korevaar, J.C. ; Tkacz, Joseph ; Johnston, Karissa ; Peres da Costa, Keith ; van Dijk, L. ; Vervloet, M. ; Pollack, Michael ; Hernandez, Paul ; Boarino, S. ; Noorduyn, Stephen G. ; Beekman-Hendricks, Wendy ; Weesie, Y.M. ; Universitat Autònoma de Barcelona
Expert national/global asthma management recommendations raise the issue whether a safe threshold of short-acting beta-2 agonist (SABA) use without concomitant inhaled corticosteroids (ICS) exists. To examine SABA and maintenance therapy associations with severe asthma exacerbations across North America and Europe. [...]
2022 - 10.1016/j.jaip.2022.02.047
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10 Núm. 9 (september 2022) , p. 2297-2309.e10  
Registre complet - Creative Commons
2.
14 p, 2.5 MB Consensus on mild asthma management : results of a modified Delphi study / Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Garcia, Gabriel (Hospital Rodolfo Rossi) ; Gemicioglu, Bilun (Istanbul University-Cerrahpasa) ; Van, Giap Vu (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Larenas-Linnemann, Désirée (Clinical Foundation and Hospital) ; Neffen, Hugo (Centro de Alergia e Inmunología y Enfermedades Respiratorias) ; Poachanukoon, Orapan (Thammasat University Hospital) ; Sagara, Hironori (Showa University School of Medicine) ; Berend, Norbert (Respiratory Franchise) ; Pizzichini, Emilio (Respiratory Franchise) ; Irusen, Elvis (GlaxoSmithKline Biologicals) ; Aggarwal, Bhumika (European Respiratory Society (ERS)) ; Eken, Volkan (Laboratorios Almirall, S.A.) ; Levy, Gur (GlaxoSmithKline) ; Universitat Autònoma de Barcelona
OBJECTIVE: In order to understand the role of regular controller inhaled corticosteroids (ICS) versus as-needed ICS-formoterol in managing mild asthma, we performed a modified Delphi procedure. METHODS: Opinions from 16 respiratory experts to three surveys and during a virtual scientific workshop helped to develop final consensus statements (pre-defined as 70% agreement). [...]
2022 - 10.1080/02770903.2022.2034850
Journal of Asthma, 2022, p. 1-13  
Registre complet - Creative Commons
3.
11 p, 594.6 KB A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease / Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Cosio, Borja G.. (Institut d'Investigació Sanitària Illes Balears) ; Arnedillo, Aurelio (Universidad de Cádiz) ; Calle Rubio, Myriam (Universidad Complutense de Madrid) ; Alcázar-Navarrete, Bernardino (Hospital de Alta Resolución de Loja) ; González, Cruz (Hospital Clínic Universitari (València)) ; Esteban, Cristóbal (Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas) ; Trigueros, Juan Antonio (Centro de Salud Menasalbas) ; Rodríguez González-Moro, José Miguel (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Quintano Jiménez, José Antonio (Centro de Salud Lucena I, Lucena, Córdoba, Spain) ; Baloira, Adolfo (Complejo Hospitalario Universitario de Pontevedra) ; Universitat Autònoma de Barcelona
According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. [...]
2017 - 10.1186/s12931-017-0682-y
Respiratory Research, Vol. 18 (november 2017)  
Registre complet - Creative Commons
4.
8 p, 665.5 KB Neumonías adquiridas en la comunidad en pacientes con enfermedad pulmonar obstructiva crónica tratados con corticoides inhalados u otros broncodilatadores. Estudio PNEUMOCORT / Morros, Rosa (Universitat Autònoma de Barcelona) ; Vedia Urgell, Cristina (Universitat Autònoma de Barcelona) ; Giner-Soriano, Maria (Universitat Autònoma de Barcelona) ; Casellas, Aina (Barcelona Institute for Global Health (ISGlobal)) ; Amado, Ester (Institut Català de la Salut) ; Baena Díez, José Miguel (Institut Català de la Salut)
Analizar el riesgo de neumonía y/o exacerbaciones en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) tratados con corticoides inhalados (CI) y no tratados con CI (NCI). Estimar el riesgo de neumonía según la dosis de CI. [...]
To analyse the risk of pneumonia and/or exacerbations in patients with chronic obstructive pulmonary disease (COPD) who receive treatment with inhaled corticosteroids (CI), in comparison with those who are not treated with inhaled corticosteroids (NCI). [...]
2019 - 10.1016/j.aprim.2018.02.007
Atencion Primaria, Vol. 51 Núm. 6 (june 2019) , p. 333-340  
Registre complet - Creative Commons
5.
10 p, 619.3 KB Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial / Rottenkolber, Marietta (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Fischer, Rainald (Pneumologische Praxis Muenchen - Pasing, Munich, Germany) ; Ibáñez, Luisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fortuny, Joan (Novartis Farmaceutica SA) ; Reynolds, Robert (Pfizer Research & Development, New York, USA) ; Amelio, Justyna (Amgen Ltd, Uxbridge, UK) ; Gerlach, Roman (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Tauscher, Martin (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Thürmann, Petra (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany) ; Hasford, Joerg (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Schmiedl, Sven (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany)
After the SMART trial evaluating the safety of salmeterol (long-acting beta-2-agonist (LABA)) in asthma patients, regulatory actions were taken to promote a guideline-adherent prescribing of LABA only to patients receiving inhaled corticosteroids (ICS). [...]
2015 - 10.1186/s12890-015-0051-x
BMC Pulmonary Medicine, Vol. 15 (may 2015)  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem